MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from CSO Ireland trade and production tables · Last verified · Editorial standards
Ireland exported €6.9bn of medicinal and pharmaceutical products in July 2026, +0.3% on the same month a year earlier, according to the CSO's goods trade figures. Over the last 12 months the total was €90.1bn, 41.8% of everything Ireland exported in goods, with 44% going to USA.
These are customs-based goods values (SITC 54); the CSO revises the most recent months in later releases, and comparisons with 2025 are affected by the exceptionally large shipments in the first half of that year, visible in the monthly table.
01
Pharma exports by month
last 5 years
Monthly value of exports, SITC 54, euro billion (CSO table TSM09).
Month
Pharma exports
Change on a year earlier
Share of goods exports
Pharma imports
July 2026
€6.88bn
+0.3%
36.4%
€1.99bn
June 2026
€6.66bn
-7.0%
36.4%
€1.85bn
May 2026
€5.61bn
-58.6%
32.9%
€1.78bn
April 2026
€7.77bn
-28.2%
41.7%
€1.79bn
March 2026
€7.03bn
-70.1%
38.7%
€1.83bn
February 2026
€5.81bn
-63.8%
37.6%
€1.94bn
January 2026
€5.89bn
-61.4%
37.4%
€1.87bn
December 2025
€5.99bn
-3.8%
37.9%
€1.29bn
November 2025
€6.54bn
-40.6%
40.4%
€2.16bn
October 2025
€6.94bn
-36.9%
42.1%
€1.69bn
September 2025
€18.51bn
+72.2%
64.5%
€1.32bn
August 2025
€6.48bn
-21.0%
40.4%
€1.71bn
July 2025
€6.86bn
-3.3%
40.8%
€2.50bn
June 2025
€7.16bn
+7.4%
42.3%
€1.97bn
May 2025
€13.55bn
+72.1%
58.3%
€1.87bn
April 2025
€10.82bn
+22.9%
50.7%
€1.82bn
March 2025
€23.50bn
+242.2%
62.6%
€2.65bn
February 2025
€16.04bn
+153.4%
64.2%
€2.03bn
January 2025
€15.24bn
+72.6%
61.2%
€1.76bn
December 2024
€6.23bn
+7.6%
39.6%
€1.13bn
November 2024
€11.01bn
+63.3%
53.3%
€1.61bn
October 2024
€11.00bn
+47.6%
51.9%
€2.10bn
September 2024
€10.75bn
+78.3%
48.2%
€1.44bn
August 2024
€8.20bn
+19.9%
47.2%
€1.83bn
July 2024
€7.10bn
+2.3%
38.9%
€1.33bn
June 2024
€6.67bn
-5.0%
39.8%
€1.16bn
May 2024
€7.87bn
+22.2%
43.6%
€1.16bn
April 2024
€8.80bn
+65.7%
45.3%
€0.89bn
March 2024
€6.87bn
-4.8%
35.8%
€0.96bn
February 2024
€6.33bn
+12.9%
39.7%
€1.09bn
January 2024
€8.83bn
+45.1%
46.7%
€1.01bn
December 2023
€5.79bn
+8.8%
42.0%
€0.85bn
November 2023
€6.74bn
-1.0%
42.0%
€1.46bn
October 2023
€7.46bn
+13.3%
42.6%
€1.36bn
September 2023
€6.03bn
-8.0%
38.0%
€0.92bn
August 2023
€6.84bn
+5.8%
42.5%
€1.01bn
Share of goods exports = pharma exports divided by total merchandise exports for the same month (both from TSM09). Download the full monthly series as CSV (from January 2015).
02
Pharma exports by year
since 2015
* 2026 covers 7 months to July 2026. Annual sums of the monthly values in TSM09, calculated by Priya Life Science.
Year
Pharma exports
Change
Share of goods exports
Pharma imports
2026
7 months
€45.6bn
—
37.3%
€13.1bn
2025
€137.6bn
+38.1%
53.2%
€22.8bn
2024
€99.7bn
+28.6%
44.5%
€15.7bn
2023
€77.5bn
-3.4%
39.5%
€12.7bn
2022
€80.2bn
+28.0%
38.4%
€11.6bn
2021
€62.7bn
+0.9%
37.8%
€9.5bn
2020
€62.1bn
+25.4%
38.3%
€8.4bn
2019
€49.5bn
+7.2%
32.5%
€7.1bn
2018
€46.2bn
+30.3%
32.8%
€11.3bn
2017
€35.5bn
+17.5%
28.9%
€8.8bn
2016
€30.2bn
-0.2%
25.3%
€6.2bn
2015
€30.2bn
—
26.9%
€5.8bn
03
Where Ireland's pharma exports go
last 12 months
Exports of SITC 54 by country of destination, sum of the last 12 months (CSO table TSM10).
By area over the same 12 months: EU 27 €37.8bn (42%), United Kingdom €3.3bn, all countries outside the EU €52.3bn (58%). The country list is the CSO's published breakdown; small markets are grouped as "other".
Destination
Last 12 months
Previous 12 months
Change
Share
USA
€39.57bn
€82.03bn
-51.8%
43.9%
Netherlands
€15.24bn
€16.02bn
-4.8%
16.9%
Belgium
€9.56bn
€13.13bn
-27.2%
10.6%
Germany
€5.35bn
€7.28bn
-26.6%
5.9%
Great Britain
€2.67bn
€1.18bn
+126.6%
3.0%
Italy
€2.61bn
€5.17bn
-49.5%
2.9%
China
€2.38bn
€1.83bn
+30.1%
2.6%
France
€1.85bn
€2.21bn
-16.1%
2.1%
Japan
€1.56bn
€1.30bn
+19.8%
1.7%
Switzerland
€1.35bn
€2.52bn
-46.3%
1.5%
Spain
€1.07bn
€962m
+11.1%
1.2%
Other countries
€931m
€866m
+7.5%
1.0%
Northern Ireland
€591m
€625m
-5.5%
0.7%
Australia
€565m
€397m
+42.4%
0.6%
Brazil
€403m
€352m
+14.4%
0.4%
Saudi Arabia
€354m
€232m
+52.5%
0.4%
Canada
€347m
€496m
-30.1%
0.4%
Hungary
€293m
€224m
+30.8%
0.3%
Sweden
€285m
€225m
+26.5%
0.3%
Poland
€257m
€249m
+3.1%
0.3%
Greece
€254m
€122m
+107.6%
0.3%
Turkey
€252m
€184m
+36.9%
0.3%
Portugal
€234m
€682m
-65.7%
0.3%
Mexico
€225m
€330m
-31.9%
0.2%
Russia
€224m
€201m
+11.4%
0.2%
Taiwan
€217m
€157m
+38.1%
0.2%
South Korea
€184m
€284m
-35.2%
0.2%
Singapore
€180m
€221m
-18.6%
0.2%
Czech Republic
€154m
€85m
+81.2%
0.2%
Austria
€143m
€176m
-18.7%
0.2%
Romania
€136m
€103m
+32.1%
0.2%
Malaysia
€129m
€62m
+109.8%
0.1%
Slovenia
€94m
€95m
-0.8%
0.1%
Denmark
€60m
€62m
-3.8%
0.1%
Slovakia
€58m
€34m
+68.6%
0.1%
Destinations with at least €50 million in the last 12 months. Values are the country of final destination as declared to customs; goods routed through hubs (for example the Netherlands and Belgium) are recorded there.
04
Factory output: the modern sector versus the rest
index, 2021 = 100
Modern sectorAll manufacturingTraditional sector
Industrial Production Index, seasonally adjusted, base year 2021 = 100 (CSO table MIM05).
Month
Modern sector
All manufacturing
Traditional sector
Modern sector, change on a year earlier
July 2026
121.0
119.1
110.6
+3.8%
June 2026
117.2
115.9
113.7
-0.8%
May 2026
116.9
115.2
107.7
-14.4%
April 2026
116.7
115.2
109.9
-2.7%
March 2026
114.0
112.9
107.8
-25.6%
February 2026
112.8
113.0
111.3
-12.8%
January 2026
106.2
107.1
110.8
-9.5%
December 2025
120.0
119.4
111.5
+6.2%
November 2025
116.4
117.9
110.6
+11.4%
October 2025
119.0
118.8
116.6
+10.8%
September 2025
113.7
115.7
114.4
+11.0%
August 2025
129.4
130.2
110.8
+28.5%
July 2025
116.6
116.3
113.8
+10.9%
June 2025
118.1
116.8
113.8
+14.2%
May 2025
136.5
131.9
116.5
+41.6%
April 2025
119.9
118.7
118.6
+19.8%
March 2025
153.2
146.0
119.2
+61.4%
February 2025
129.4
127.7
112.1
+47.4%
January 2025
117.3
117.1
113.2
+20.7%
December 2024
113.0
113.1
122.7
+7.7%
November 2024
104.5
107.9
113.7
-4.8%
October 2024
107.4
109.3
117.5
+17.5%
September 2024
102.4
105.6
119.3
+2.6%
August 2024
100.7
104.8
116.5
+8.3%
The CSO does not publish a pharmaceuticals-only monthly production index (the NACE 21 line is suppressed for confidentiality). The "modern sector" it publishes instead groups pharmaceuticals (NACE 21) with chemicals (20), computers and electronics (26, 27), medical and dental instruments (325) and reproduction of recorded media (182); the "traditional sector" is every other manufacturing industry. Month-to-month swings in the modern sector are large and mostly reflect pharmaceutical output.
What these figures are. Trade values are the CSO's customs-based merchandise trade statistics for SITC division 54, medicinal and pharmaceutical products, in current euro. They do not include services, royalties or intellectual-property flows, and active ingredients classified as organic chemicals (SITC 51) are outside this division. The CSO publishes the latest months as preliminary and revises them in later releases; this page shows whatever the CSO publishes at the time of the last sync. 12-month totals, annual sums, shares and percentage changes are calculated by Priya Life Science from those published values.
How this page is built
Every monthly value is the CSO's published figure, re-used under the CSO's Creative Commons Attribution 4.0 licence. The 12-month totals, annual sums, shares and percentage changes are calculated here from those values and labelled as such.
A job queries the CSO's PxStat API for the three tables after each monthly release and stores the series. No AI drafting and no editorial pass. See our editorial standards. The the CSO data on this page was last retrieved on 28 Sep 2026.
Please verify before you rely on this.
This page is general information for life-science and pharmaceutical professionals. It is
not medical advice, and it has not been reviewed by a clinician — our editorial
team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most
recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC)
and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not
automatically interchangeable, and approvals, brand names and indications differ between the US, the
EU/Ireland (EMA/HPRA) and other regions.
Spotted an error? Tell us — we correct promptly and log it.
We value your privacy
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.